Altamont Pharmaceutical Holdings Overview

  • Investor Type
  • Holding Company

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 22

  • Portfolio
  • 4

  • Exits
  • 20

Exits

Altamont Pharmaceutical Holdings General Information

Company Description

Altamont Pharmaceutical Holdings is a healthcare investment firm that seeks to invest in biotech companies with an emphasis on private investment in public equity (PIPE) offerings. The company invests in the vision of entrepreneurs and scientists to cure life-threatening diseases and reduce the effects of chronic disease. The firm was founded in 2017 and it is based in Austin, Texas.

Business Details

Formerly Known As
Altamont Phamaceutical Holdings, Llc
Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Holding Company
Other Investor Types
Accelerator/Incubator
Corporate Office
  • 600 Congress Avenue
  • 14th Floor
  • Austin, TX 78701
  • United States
+1 (512)

Altamont Pharmaceutical Holdings Investments (22)

Altamont Pharmaceutical Holdings’s most recent investment was a with IO Biotech for . The deal was made on 11-Aug-2023.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
IO Biotech 11-Aug-2023 Drug Discovery Bankruptcy: Liquidation
Dialectic Therapeutics 01-Mar-2023 Drug Discovery Clinical Trials - Phase 1
Cessation Therapeutics 11-May-2022 Drug Discovery Generating Revenue
Angarus Therapeutics 22-Jun-2021 Drug Discovery Out of Business
Amygdala Neurosciences 28-Apr-2021 Seed Round Drug Discovery Pre-Clinical Trials
You’re viewing 5 of 22 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Altamont Pharmaceutical Holdings Exits (20)

Altamont Pharmaceutical Holdings has made a total of 20 exits. Its latest exit was from IO Biotech on 01-Apr-2026. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
IO Biotech 01-Apr-2026
InflaRx 18-Feb-2025
MeiraGTx 12-Aug-2024
DTech Liquidating 18-Jun-2024
Urogen Pharma 17-Jun-2024 Public Investment 2nd Offering
You’re viewing 5 of 20 exits. Get the full list »

Altamont Pharmaceutical Holdings Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Altamont Pharmaceutical Holdings FAQs

  • What is Altamont Pharmaceutical Holdings?

    Altamont Pharmaceutical Holdings is a healthcare investment firm that seeks to invest in biotech companies with an emphasis on private investment in public equity (PIPE) offerings.

  • When was Altamont Pharmaceutical Holdings founded?

    Altamont Pharmaceutical Holdings was founded in 2017.

  • Where is Altamont Pharmaceutical Holdings headquartered?

    Altamont Pharmaceutical Holdings is headquartered in Austin, TX.

  • How many investments has Altamont Pharmaceutical Holdings made?

    Altamont Pharmaceutical Holdings has made 22 investments.

  • What has Altamont Pharmaceutical Holdings invested in?

    Altamont Pharmaceutical Holdings has made numerous investments in companies like IO Biotech, Dialectic Therapeutics, and Cessation Therapeutics within the Drug Discovery industry.

  • What has Altamont Pharmaceutical Holdings invested in recently?

    Altamont Pharmaceutical Holdings's latest investment was on 11-Aug-2023 in IO Biotech, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process